Caring for the Ages
June 8, 2024
Showing 601 - 610 of 7518 results
Caring for the Ages
June 8, 2024
A Year in With Society Executive Director Michelle Zinnert
Caring for the Ages
June 8, 2024
Introducing PALTmed: Empowering Interdisciplinary Clinical Practice in Post-Acute and Long-Term Care
Caring for the Ages
June 8, 2024
Providing Space for Those Passionate About Making a Difference
JAMDA
June 8, 2024
Enablers and Barriers for End-of-Life Symptom Management Medications in Long-Term Care Homes: A Qualitative Study
Long-term care (LTC) homes provide personal and medical care 24/7 to individuals unable to live at home due to illness or disability and are often the final place of care and death for their residents. Therefore, LTC homes are tasked with providing quality end-of-life care, often requiring injectable sympt...
JAMDA
June 8, 2024
A Longitudinal Study of the Use and Effects of Fall-Risk-Increasing Drugs in Residential Aged Care
Fall-risk-increasing drugs (FRIDs)—psychotropics and cardiovascular disease (CVD) drugs—may elevate the risk of falling, with strong evidence observed in psychotropic FRIDs, whereas findings from cardiovascular disease (CVD) FRIDs remain inconclusive. Existing studies on FRIDs and falls are often hampered ...
JAMDA
June 8, 2024
Barriers and Enablers for Deprescribing Diabetes Medication
JAMDA
June 8, 2024
Prevalence and Correlates of Antipsychotic Medication Use in Oregon Assisted Living
Investigate how assisted living and residential care (AL/RC) and memory care (MC) contexts are associated with the 90-day prevalence of antipsychotic medication use (APU), considered a quality measure in long-term care.
JAMDA
June 8, 2024
How Do Discrepancies between Subjective and Objective Health Predict the Risk of Injurious Falls? A Study of Community-Dwelling Swedish Older Adults
Previous studies demonstrated that discrepancies between subjective and objective health measures are associated with physical and mental health–related outcomes in older adults. We investigate whether such discrepancies are also associated with risk of injurious falls in community-dwelling Swedish older a...
Policy Snapshot
June 7, 2024
National Coverage Determination 200.3: Monoclonal Antibodies for the Treatment of Alzheimer’s Disease
Learn about coverage for monoclonal antibodies for the treatment of Alzheimer’s disease, effective April 7, 2022.
